🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the efficacy and safety of mosunetuzumab in combinat...
Status
Active Not Recruiting
Location
City of Hope Cancer Center
Start Date
2022-04-25
Trial ID
NCT05171647
Treatments Being Tested
This study will evaluate the efficacy, safety, and pharmacokinetics of mosu...
Status
Active Not Recruiting
Location
Infirmary Cancer Care
Start Date
2022-02-01
Trial ID
NCT05207670
Treatments Being Tested
The purpose of this study is to test a new medication called Mosunetuzumab ...
Status
Recruiting
Location
University of Miami
Start Date
2024-11-19
Trial ID
NCT06569680
Treatments Being Tested
This is a multi-center, open-label, interventional clinical trial designed ...
Status
Recruiting
Location
Rambam Health Care Campus
Start Date
2026-01-05
Trial ID
NCT07191249
The goal of this study is to learn about the safety and effectiveness of th...
Status
Active Not Recruiting
Location
Weill Cornell Medicine/NewYork-Presbyterian Hospital
Start Date
2023-11-01
Trial ID
NCT05994235
Treatments Being Tested
This study will evaluate the safety, tolerability, pharmacokinetics, pharma...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham School of Medicine
Start Date
2018-09-25
Trial ID
NCT03671018
Treatments Being Tested
This study will assess the safety, tolerability, pharmaokinetics, and preli...
Status
Recruiting
Location
Mayo Clinic Rochester
Start Date
2022-03-07
Trial ID
NCT05091424
Treatments Being Tested
This study will evaluate the safety, efficacy, pharmacokinetics, and immuno...
Status
Active Not Recruiting
Location
City of Hope National Medical Center
Start Date
2020-08-12
Trial ID
NCT04246086
Treatments Being Tested
This study will evaluate the safety, efficacy, and pharmacokinetics of mosu...
Status
Terminated
Location
USC Norris Comprehensive Cancer Center
Start Date
2022-05-10
Trial ID
NCT05315713
Treatments Being Tested
This is a Phase 1/2 dose-escalation study of BTCT4465A (Mosunetuzumab) admi...
Status
Completed
Location
University of California San Diego Moores Cancer Center
Start Date
2015-09-15
Trial ID
NCT02500407
Treatments Being Tested